1st Edition
Chronic Myeloproliferative Disorders
272 Pages
by
CRC Press
272 Pages
by
CRC Press
Also available as eBook on:
With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative... Read more
Part I - Bcr/Abl positive Chronic Myeloproliferative Disorders 1. History 2. Cytogenetics & Molecular Biology 3. Risk Stratification Models 4. Clinical Aspects 5. Current Treatment Options 6. Emerging treatment Options 7. Transplant Options 8. Monitoring response to therapy 9. Immunotherapy 10. Furture Directions Part II - Bcr/Abl negative Chronic Myeloproliferative Disorders 1. History 2. Ph-negative Chronic Myelproliferative Leukemias 3. Systemic mastocytosis 4. Polycythemia vera 5. Idiopathic myelofibrosis 6. Essential thrombocythemia 7. Transplant Options 8. Therapeutic strategies
Biography
TARIQ I MUGHAL is Professor of Medicine and Haematology/Oncology at the University of Texas Southwestern Medical School, Dallas, USA and Consultant Haematologist at Guy’s & St Thomas’ Hospitals, London UK
JOHN M. GOLDMAN is Professor of Haematology at Imperial College London, Hammersmith Hospital, London, UK.
